News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitget UEX Daily | Trump Claims Quick End to Iran Action; Crude Oil Pulls Back from Highs, US Stocks Rebound; Japan's Cryptocurrency Asset Trading Surges (March 10, 2026)2Oracle Q3 Earnings Preview: Limited Performance Boost, Market Seeks Long-Term Optimistic Outlook3Wall Street funneled $540M into US Solana ETFs in Q4: Bloomberg
Sphere 3D’s CEO Puts Faith in Future RSUs Instead of Cash—Savvy Investors Hold Off Until Merger is Confirmed
101 finance·2026/03/06 23:00
Charles Schwab Earnings Soar on 18.9% Revenue Surge and $12.2 Trillion Assets Despite 132nd Trading Rank
101 finance·2026/03/06 22:57
Carnival's Shares Plummets 5.04% as Geopolitical Tensions and Oil Spikes Send $930M Volume to 131st Rank
101 finance·2026/03/06 22:57
AT&T's AI Push Drives 5x ROI but Stock Falls 1.14% as Trading Volume Ranks 109th
101 finance·2026/03/06 22:54

Where Should You Invest $20,000 Now for a Reliable and Consistent Return
101 finance·2026/03/06 22:54
Palo Alto Networks Climb on AI Cybersecurity Push Despite 21% Volume Plunge Ranked 97th in Trading Activity
101 finance·2026/03/06 22:54
Uber Stock Falls 0.41% Amid Launch of 102nd Bus Route in India, Trading Volume Hits $1.11 Billion
101 finance·2026/03/06 22:51
Ciena's 1.71% Dip Ranks 96th in Volume Amid Analyst Upgrades and Cloud Infrastructure Booms
101 finance·2026/03/06 22:48
Parker-Hannifin's 98th-Ranked Trading Volume Hides 4.32% Slide After 53% Annual Rally
101 finance·2026/03/06 22:48
Flash
10:45
US Stock Pre-market Crypto Stocks Soar, Strategy Up 2.79%BlockBeats News, March 10th, according to Bitget market data, pre-market crypto concept stocks in the US rose across the board, including:
MicroStrategy (MSTR) up by 2.79%;
an exchange (COIN) up by 3.11%;
Circle (CRCL) up by 1.66%;
MARA Holdings (MARA) up by 1.85%;
Riot Blockchain (RIOT) up by 2.11%;
Bit Digital Immersion (BMNR) up by 1.16%;
StrongNode (SNODE) up by 1.57%;
SharpLink Gaming (SBET) up by 1.97%.
10:41
Owlet Inc. has filed a prospectus with the U.S. Securities and Exchange Commission (SEC), showing that the company’s registered holders plan to resell up to 9.6 million shares of Class A common stock.This share resale does not involve the issuance of new shares by the company; all shares sold are provided by existing shareholders. According to documents disclosed by the SEC, this prospectus is intended to provide a compliant channel for registered holders to sell their shares. The market will closely monitor the potential impact of this large-scale share resale on the company's equity structure and secondary market liquidity.
10:41
According to the latest filing submitted to the U.S. Securities and Exchange Commission, healthcare giant Concentrix has explicitly stated its plan to reaffirm its 2026 financial targets.The company expects that by then, its diluted earnings per share calculated under GAAP will exceed $1.98, while adjusted earnings per share are targeting the important threshold of over $3.00. The confirmation of this guidance highlights management's strong confidence in the company's medium- and long-term profitability. Despite policy changes and cost pressures in the healthcare industry, Conxico has demonstrated strong resilience in continuously creating shareholder value through refined operations and strategic planning. Notably, the establishment of dual earnings per share metrics provides investors with a more comprehensive performance evaluation dimension, encompassing both standard financial performance and core operating results after excluding special items. As the 2026 milestone approaches, the market will closely watch how the company achieves these ambitious goals through business optimization and technological innovation. The reiteration of this guidance not only consolidates capital market expectations for the company, but also conveys management's precise control over the future growth trajectory.
Trending news
MoreAccording to the latest filing submitted to the U.S. Securities and Exchange Commission, healthcare giant Concentrix has explicitly stated its plan to reaffirm its 2026 financial targets.
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Elevance Health has once again reaffirmed its performance outlook for fiscal year 2026, expecting adjusted shareholder earnings to remain at no less than $25.50 per diluted share.
News